Latest filing published 03 May 2023 for Bristol Myers Squibb Co, €14k.
Insider track record
Sharon Greenlees: trading record in brief
Sharon Greenlees discloses dealings in Bristol Myers Squibb Co to SEC (Form 4). Altogether 5 filings, all relating to 2 May 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 3 May 2023, reports a share grant of €14k in Bristol Myers Squibb Co. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sharon Greenlees
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 227 shares@ US$68.1065.6% of flowCommon Stock, $0.10 par valueSEC:0000014272-23-000111:2
- 119 shares@ US$68.1034.4% of flowCommon Stock, $0.10 par valueSEC:0000014272-23-000111:4
- 62 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000111:1
- 328 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000111:3
- 689 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000111:0
5 of 5 declarations
